Detalles de la búsqueda
1.
Retreatment of Patients With Metastatic Cutaneous Melanoma Who Relapse After Elective Checkpoint Inhibitor Discontinuation After a Complete Remission.
Oncologist
; 28(5): e270-e275, 2023 05 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36852837
2.
Real-world clinical outcomes of patients with stage IIB or IIC cutaneous melanoma treated at US community oncology clinics.
Future Oncol
; 18(33): 3755-3767, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36346064
3.
Hedgehog Inhibitor Induction with Addition of Concurrent Superficial Radiotherapy in Patients with Locally Advanced Basal Cell Carcinoma: A Case Series.
Oncologist
; 26(12): e2247-e2253, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34472658
4.
Cautious addition of targeted therapy to PD-1 inhibitors after initial progression of BRAF mutant metastatic melanoma on checkpoint inhibitor therapy.
BMC Cancer
; 21(1): 1187, 2021 Nov 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34743688
5.
Extension of overall survival beyond objective responses in patients with metastatic renal cell carcinoma treated with high-dose interleukin-2.
Cancer Immunol Immunother
; 65(8): 941-9, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27277816
6.
Limited genomic heterogeneity of circulating melanoma cells in advanced stage patients.
Phys Biol
; 12(1): 016008, 2015 Jan 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-25574741
7.
The Effect of Non-Overlapping Somatic Mutations in BRAF, NRAS, NF1, or CKIT on the Incidence and Outcome of Brain Metastases during Immune Checkpoint Inhibitor Therapy of Metastatic Melanoma.
Cancers (Basel)
; 16(3)2024 Jan 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38339344
8.
Neoadjuvant ipilimumab plus nivolumab therapy as a potential organ preservation strategy in mucosal melanoma: case report.
Front Oncol
; 14: 1301424, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38549929
9.
Relationships between survival and real-world recurrence-free survival or distant metastasis-free survival among patients with completely resected stage IIB or IIC melanoma.
Melanoma Res
; 2024 May 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38814728
10.
A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART SWOG 1609 Cohort 47) in Patients with Gestational Trophoblastic Neoplasia.
Clin Cancer Res
; 30(1): 33-38, 2024 01 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37882676
11.
Sustained Suppression of Gorlin Syndrome-Associated Basal Cell Carcinomas with Vismodegib or Sonidegib: A Case Series.
Curr Oncol
; 30(10): 9156-9167, 2023 10 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-37887561
12.
Lack of Influence of Non-Overlapping Mutations in BRAF, NRAS, or NF1 on 12-Month Best Objective Response and Long-Term Survival after Checkpoint Inhibitor-Based Treatment for Metastatic Melanoma.
Cancers (Basel)
; 15(13)2023 Jul 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37444637
13.
Effectiveness and toxicity of cetuximab with concurrent RT in locally advanced cutaneous squamous cell skin cancer: a case series.
Oncotarget
; 14: 709-718, 2023 Jul 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37417890
14.
Real-World nivolumab dosing patterns and safety outcomes in patients receiving adjuvant therapy for melanoma.
Cancer Med
; 12(3): 2378-2388, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35880244
15.
Two phase 2 trials of the novel Akt inhibitor perifosine in patients with advanced renal cell carcinoma after progression on vascular endothelial growth factor-targeted therapy.
Cancer
; 118(24): 6055-62, 2012 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22674198
16.
Outcome of Elective Checkpoint Inhibitor Discontinuation in Patients with Metastatic Melanoma Who Achieved a Complete Remission: Real-World Data.
Biomedicines
; 10(5)2022 May 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-35625881
17.
Elective Checkpoint Inhibitor Discontinuation in Metastatic Solid Tumor Patients: A Case Series.
Ann Case Rep
; 7(4)2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36506754
18.
A multi-center phase II evaluation of the small molecule survivin suppressor YM155 in patients with unresectable stage III or IV melanoma.
Invest New Drugs
; 29(1): 161-6, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19830389
19.
A phase II multicenter study of ipilimumab with or without dacarbazine in chemotherapy-naïve patients with advanced melanoma.
Invest New Drugs
; 29(3): 489-98, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-20082117
20.
A nonpeptidyl mimic of superoxide dismutase, M40403, inhibits dose-limiting hypotension associated with interleukin-2 and increases its antitumor effects.
Nat Med
; 9(6): 750-5, 2003 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-12730689